Page last updated: 2024-09-02

ecopipam and oxidopamine

ecopipam has been researched along with oxidopamine in 2 studies

Compound Research Comparison

Studies (ecopipam)	Trials (ecopipam)	Recent Studies (post-2010) (ecopipam)	Studies (oxidopamine)	Trials (oxidopamine)	Recent Studies (post-2010) (oxidopamine)
147	18	34	8,630	6	2,407

Protein Interaction Comparison

Protein	Taxonomy	ecopipam (IC50)	oxidopamine (IC50)
Glyceraldehyde-3-phosphate dehydrogenase	Homo sapiens (human)		8
DNA repair protein RAD52 homolog	Homo sapiens (human)		0.779

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Breese, GR; Criswell, HE; Mueller, RA	1
Emmi, A; Rajabi, H; Stewart, J	1

Other Studies

2 other study(ies) available for ecopipam and oxidopamine

Article	Year
Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1992, Volume: 7, Issue:2 Topics: Animals; Animals, Newborn; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Female; Levodopa; Motor Activity; Oxidopamine; Papaverine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Self Mutilation; Sympathectomy, Chemical; Tetrahydroisoquinolines	1992
Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists. The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, May-15, Volume: 17, Issue:10 Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Male; Microdialysis; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D5; Substantia Nigra; Sympatholytics	1997

Article

Year

Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1992, Volume: 7, Issue:2

Topics: Animals; Animals, Newborn; Benzazepines; Dopamine Antagonists; Dose-Response Relationship, Drug; Ergolines; Female; Levodopa; Motor Activity; Oxidopamine; Papaverine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Self Mutilation; Sympathectomy, Chemical; Tetrahydroisoquinolines

1992

Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with D1/D5, but not D2, dopamine receptor antagonists.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 1997, May-15, Volume: 17, Issue:10

Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Benzazepines; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Homovanillic Acid; Male; Microdialysis; Oxidopamine; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D5; Substantia Nigra; Sympatholytics

1997